Nephros, Inc.
NEPH
$1.89
-$0.08-4.06%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.87M | 3.52M | 3.25M | 3.52M | 3.25M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.87M | 3.52M | 3.25M | 3.52M | 3.25M |
| Cost of Revenue | 1.40M | 1.37M | 1.34M | 1.34M | 1.23M |
| Gross Profit | 2.48M | 2.15M | 1.91M | 2.19M | 2.02M |
| SG&A Expenses | 1.87M | 1.72M | 1.94M | 2.14M | 2.41M |
| Depreciation & Amortization | 34.00K | 34.00K | 34.00K | 33.00K | 51.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.55M | 3.31M | 3.57M | 3.72M | 3.90M |
| Operating Income | 317.00K | 206.00K | -317.00K | -200.00K | -649.00K |
| Income Before Tax | 364.00K | 183.00K | -289.00K | -169.00K | -654.00K |
| Income Tax Expenses | 15.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | 349.00K | 183.00K | -289.00K | -169.00K | -654.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 349.00K | 183.00K | -289.00K | -169.00K | -654.00K |
| EBIT | 317.00K | 206.00K | -317.00K | -200.00K | -649.00K |
| EBITDA | 352.00K | 239.00K | -282.00K | -166.00K | -598.00K |
| EPS Basic | 0.03 | 0.02 | -0.03 | -0.02 | -0.06 |
| Normalized Basic EPS | 0.02 | 0.01 | -0.02 | -0.01 | -0.04 |
| EPS Diluted | 0.03 | 0.02 | -0.03 | -0.02 | -0.06 |
| Normalized Diluted EPS | 0.02 | 0.01 | -0.02 | -0.01 | -0.04 |
| Average Basic Shares Outstanding | 10.54M | 10.54M | 10.51M | 10.50M | 10.49M |
| Average Diluted Shares Outstanding | 10.56M | 10.58M | 10.51M | 10.50M | 10.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |